Avanir Pharmaceuticals
As of the edition of 20 October 2026, Avanir Pharmaceuticals runs 5 drugs, 1 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 1 |
| Went quiet | 4 |
| Total | 5 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Sumatriptan | none listed | 1 |
A route B row is one company at one target.
Where its trials are
- Nervous system: 5 trials led
- Immune system: 2 trials led
- Mental health: 2 trials led